← 產業報告目錄
AI in Respiratory Diseases Market Size, Share & Trends Analysis Report By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By Imaging Type (MRI, CT Scan, ePRO), By End-use (Hospital, Diagnostic Centers, Ambulatory Surgical centers, Others), By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 ICT & Media出版日期 2026-02-26頁數 180報告編號 INSIGHTACE-e64226ce05
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the AI in Respiratory Diseases Market globally will surge at a 29.4% CAGR during 2025–2034.
AI in Respiratory Diseases encompasses ai is revolutionizing the field of respiratory diseases by aiding in early diagnosis, personalized treatment, and remote monitoring. The sector has gained traction as organizations seek innovative approaches to address evolving technology and communications challenges.
Market momentum is bolstered by surging call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI in Respiratory Diseases Market Snapshot
Chapter 4. Global AI in Respiratory Diseases Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Indication Estimates & Trend Analysis
5.1. By Indication, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Indication:
5.2.1. Chronic Obstructive Pulmonary Disease
5.2.2. Interstitial Lung Disease
5.2.3. Pulmonary Infection
Chapter 6. Market Segmentation 2: By Imaging Type Estimates & Trend Analysis
6.1. By Imaging Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Imaging Type:
6.2.1. MRI
6.2.2. CT Scan
6.2.3. ePRO
Chapter 7. Market Segmentation 3: By End-use Estimates & Trend Analysis
7.1. By End-use & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By End-use:
7.2.1. Hospitals
7.2.2. Diagnostic Centers
7.2.3. Ambulatory Surgical centers
7.2.4. Others
Chapter 8. AI in Respiratory Diseases Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America AI in Respiratory Diseases Market revenue (US$ Million) estimates and forecasts By Indication, 2021-2034
8.1.2. North America AI in Respiratory Diseases Market revenue (US$ Million) estimates and forecasts By Imaging Type, 2021-2034
8.1.3. North America AI in Respiratory Diseases Market revenue (US$ Million) estimates and forecasts By End-use, 2021-2034
8.1.4. North America AI in Respiratory Diseases Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe AI in Respiratory Diseases Market revenue (US$ Million) By Indication, 2021-2034
8.2.2. Europe AI in Respiratory Diseases Market revenue (US$ Million) By Imaging Type, 2021-2034
8.2.3. Europe AI in Respiratory Diseases Market revenue (US$ Million) By End-use, 2021-2034
8.2.4. Europe AI in Respiratory Diseases Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific AI in Respiratory Diseases Market revenue (US$ Million) By Indication, 2021-2034
8.3.2. Asia Pacific AI in Respiratory Diseases Market revenue (US$ Million) By Imaging Type, 2021-2034
8.3.3. Asia Pacific AI in Respiratory Diseases Market revenue (US$ Million) By End-use, 2021-2034
8.3.4. Asia Pacific AI in Respiratory Diseases Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America AI in Respiratory Diseases Market revenue (US$ Million) By Indication, (US$ Million) 2021-2034
8.4.2. Latin America AI in Respiratory Diseases Market revenue (US$ Million) By Imaging Type, (US$ Million) 2021-2034
8.4.3. Latin America AI in Respiratory Diseases Market revenue (US$ Million) By End-use, (US$ Million) 2021-2034
8.4.4. Latin America AI in Respiratory Diseases Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa AI in Respiratory Diseases Market revenue (US$ Million) By Indication, (US$ Million) 2021-2034
8.5.2. Middle East & Africa AI in Respiratory Diseases Market revenue (US$ Million) By Imaging Type, (US$ Million) 2021-2034
8.5.3. Middle East & Africa AI in Respiratory Diseases Market revenue (US$ Million) By End-use, (US$ Million) 2021-2034
8.5.4. Middle East & Africa AI in Respiratory Diseases Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ArtiQ
9.2.2. Dectrocel Healthcare
9.2.3. DeepMind Health
9.2.4. GE Healthcare
9.2.5. Icometrix
9.2.6. Infervision
9.2.7. Philips Healthcare
9.2.8. PneumoWave
9.2.9. Respiray
9.2.10. Siemens Healthineers
9.2.11. Swaasa AI
9.2.12. THIRONA
9.2.13. Verily
9.2.14. VIDA Diagnostics Inc
9.2.15. Zynnon
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們